| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 9.39e-12 | 6 | 89 | 5 | GO:0004499 | |
| GeneOntologyMolecularFunction | hypotaurine monooxygenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047822 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.25e-08 | 40 | 89 | 6 | GO:0016709 | |
| GeneOntologyMolecularFunction | NADP binding | 3.33e-07 | 62 | 89 | 6 | GO:0050661 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.26e-05 | 115 | 89 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.38e-05 | 11 | 89 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 6.31e-05 | 94 | 89 | 5 | GO:0050660 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 1.17e-04 | 4 | 89 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.27e-04 | 109 | 89 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RALA RALB KIF26A ABCB5 DDX42 ABCC2 POLQ RAB1A ATP2A1 ATP2A2 ATP2A3 GSPT1 | 1.64e-04 | 775 | 89 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.32e-04 | 194 | 89 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RALA RALB KIF26A ABCB5 DDX42 ABCC2 POLQ RAB1A ATP2A1 ATP2A2 ATP2A3 GSPT1 | 3.39e-04 | 839 | 89 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RALA RALB KIF26A ABCB5 DDX42 ABCC2 POLQ RAB1A ATP2A1 ATP2A2 ATP2A3 GSPT1 | 3.43e-04 | 840 | 89 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RALA RALB KIF26A ABCB5 DDX42 ABCC2 POLQ RAB1A ATP2A1 ATP2A2 ATP2A3 GSPT1 | 3.43e-04 | 840 | 89 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 5.49e-04 | 36 | 89 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 5.49e-04 | 36 | 89 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | pre-miRNA binding | 6.93e-04 | 9 | 89 | 2 | GO:0070883 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.87e-04 | 441 | 89 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.21e-03 | 178 | 89 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.65e-03 | 614 | 89 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.99e-03 | 15 | 89 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 2.26e-03 | 16 | 89 | 2 | GO:0008242 | |
| GeneOntologyMolecularFunction | G protein activity | 2.32e-03 | 59 | 89 | 3 | GO:0003925 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.29e-06 | 127 | 89 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.07e-06 | 93 | 89 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.46e-06 | 153 | 89 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 4.49e-06 | 217 | 89 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 4.69e-06 | 100 | 89 | 6 | GO:0061337 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 7.08e-06 | 29 | 89 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 1.84e-05 | 2 | 89 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 2.64e-05 | 81 | 89 | 5 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | FLNA XIRP1 DSG2 ASIC1 ABCB5 RAPGEF4 GRID2 ATP2A2 SLC1A6 SNTA1 RYR2 | 2.84e-05 | 559 | 89 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 3.51e-05 | 43 | 89 | 4 | GO:0086004 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 3.73e-05 | 87 | 89 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 5.51e-05 | 3 | 89 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid oxidation | 6.05e-05 | 18 | 89 | 3 | GO:0046322 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 8.07e-05 | 53 | 89 | 4 | GO:1903115 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 8.59e-05 | 167 | 89 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | NADP metabolic process | 1.00e-04 | 56 | 89 | 4 | GO:0006739 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.02e-04 | 249 | 89 | 7 | GO:0008016 | |
| GeneOntologyBiologicalProcess | myoblast differentiation involved in skeletal muscle regeneration | 1.10e-04 | 4 | 89 | 2 | GO:0014835 | |
| GeneOntologyBiologicalProcess | actin filament-based process | VIL1 RALA FLNA FLNC XIRP1 DSG2 SRCIN1 SPECC1L ARHGEF11 ATP2A1 ATP2A2 SNTA1 RYR2 | 1.42e-04 | 912 | 89 | 13 | GO:0030029 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.49e-04 | 62 | 89 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cholesterol biosynthetic process | 1.79e-04 | 65 | 89 | 4 | GO:0006695 | |
| GeneOntologyBiologicalProcess | secondary alcohol biosynthetic process | 1.79e-04 | 65 | 89 | 4 | GO:1902653 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA processing | 1.83e-04 | 5 | 89 | 2 | GO:1903800 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 1.83e-04 | 5 | 89 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | action potential | 2.36e-04 | 201 | 89 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 2.62e-04 | 29 | 89 | 3 | GO:0032469 | |
| GeneOntologyBiologicalProcess | sterol biosynthetic process | 2.66e-04 | 72 | 89 | 4 | GO:0016126 | |
| GeneOntologyBiologicalProcess | positive regulation of ATPase-coupled calcium transmembrane transporter activity | 2.73e-04 | 6 | 89 | 2 | GO:1901896 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 2.90e-04 | 30 | 89 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 2.91e-04 | 209 | 89 | 6 | GO:0006694 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 2.96e-04 | 74 | 89 | 4 | GO:0070918 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.07e-04 | 298 | 89 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | regulation of system process | FLNA ACACB DSG2 RAPGEF4 TNNC2 ATP2A1 ATP2A2 ATP2A3 DICER1 SNTA1 RYR2 | 3.14e-04 | 734 | 89 | 11 | GO:0044057 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 3.33e-04 | 619 | 89 | 10 | GO:0006163 | |
| GeneOntologyBiologicalProcess | muscle contraction | 3.35e-04 | 400 | 89 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 3.64e-04 | 141 | 89 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | calcium ion import into sarcoplasmic reticulum | 3.81e-04 | 7 | 89 | 2 | GO:1990036 | |
| GeneOntologyBiologicalProcess | heart process | 3.82e-04 | 309 | 89 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 5.00e-04 | 652 | 89 | 10 | GO:0072521 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 5.25e-04 | 326 | 89 | 7 | GO:1903522 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 5.43e-04 | 37 | 89 | 3 | GO:0086005 | |
| GeneOntologyBiologicalProcess | muscle system process | 5.88e-04 | 547 | 89 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 5.98e-04 | 89 | 89 | 4 | GO:0055117 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 6.10e-04 | 438 | 89 | 8 | GO:0032970 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | TPST1 DGLUCY ASRGL1 FMO2 FMO3 FMO4 ACACB GAPDH ACLY SCP2 ABCC2 GPT2 FABP4 | 6.24e-04 | 1064 | 89 | 13 | GO:0006082 |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 6.34e-04 | 39 | 89 | 3 | GO:0006084 | |
| GeneOntologyBiologicalProcess | NADPH oxidation | 6.50e-04 | 9 | 89 | 2 | GO:0070995 | |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 7.05e-04 | 163 | 89 | 5 | GO:0008203 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 7.24e-04 | 684 | 89 | 10 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 7.83e-04 | 691 | 89 | 10 | GO:0006753 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 9.05e-04 | 44 | 89 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | 9.95e-04 | 176 | 89 | 5 | GO:1902652 | |
| GeneOntologyBiologicalProcess | sterol metabolic process | 1.02e-03 | 177 | 89 | 5 | GO:0016125 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid oxidation | 1.03e-03 | 46 | 89 | 3 | GO:0046320 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 1.15e-03 | 106 | 89 | 4 | GO:0032091 | |
| GeneOntologyBiologicalProcess | miRNA processing | 1.17e-03 | 48 | 89 | 3 | GO:0035196 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA-mediated gene silencing | 1.18e-03 | 12 | 89 | 2 | GO:2000637 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.18e-03 | 12 | 89 | 2 | GO:0098911 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | TPST1 DIP2A FMO2 FMO5 ACACB SYNJ1 GAPDH ACLY TPTE2 SCP2 MAGI3 HSD11B1 ADCY3 | 1.20e-03 | 1142 | 89 | 13 | GO:0019637 |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.21e-03 | 376 | 89 | 7 | GO:0008202 | |
| GeneOntologyBiologicalProcess | acyl-CoA biosynthetic process | 1.24e-03 | 49 | 89 | 3 | GO:0071616 | |
| GeneOntologyBiologicalProcess | thioester biosynthetic process | 1.24e-03 | 49 | 89 | 3 | GO:0035384 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 1.36e-03 | 111 | 89 | 4 | GO:0006942 | |
| GeneOntologyBiologicalProcess | positive regulation of post-transcriptional gene silencing by RNA | 1.39e-03 | 13 | 89 | 2 | GO:1900370 | |
| GeneOntologyBiologicalProcess | positive regulation of post-transcriptional gene silencing | 1.39e-03 | 13 | 89 | 2 | GO:0060148 | |
| GeneOntologyBiologicalProcess | regulation of ATPase-coupled calcium transmembrane transporter activity | 1.39e-03 | 13 | 89 | 2 | GO:1901894 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 6.36e-06 | 9 | 90 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.24e-05 | 11 | 90 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 4.18e-05 | 45 | 90 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.34e-04 | 114 | 90 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | KSR1 FMO2 FMO3 FMO4 FMO5 TPTE2 ALG5 CYP51A1 CYB5R3 HSD11B1 RAB1A ATP2A1 ATP2A2 ATP2A3 RYR2 | 3.91e-04 | 1293 | 90 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | KSR1 FMO2 FMO3 FMO4 FMO5 TPTE2 ALG5 CYP51A1 CYB5R3 HSD11B1 RAB1A ATP2A1 ATP2A2 ATP2A3 RYR2 | 4.10e-04 | 1299 | 90 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | KSR1 FMO2 FMO3 FMO4 FMO5 TPTE2 ALG5 CYP51A1 CYB5R3 HSD11B1 RAB1A ATP2A1 ATP2A2 ATP2A3 RYR2 | 5.13e-04 | 1327 | 90 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.69e-04 | 88 | 90 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 8.41e-04 | 43 | 90 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.18e-03 | 107 | 90 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | lipid droplet | 1.59e-03 | 116 | 90 | 4 | GO:0005811 | |
| MousePheno | abnormal myocardial fiber calcium currents | 7.82e-05 | 3 | 72 | 2 | MP:0020346 | |
| MousePheno | abnormal myocardial fiber sodium currents | 7.82e-05 | 3 | 72 | 2 | MP:0020347 | |
| MousePheno | embryonic lethality between somite formation and embryo turning, complete penetrance | 8.38e-05 | 87 | 72 | 5 | MP:0011097 | |
| Domain | FMO-like | 2.29e-09 | 5 | 88 | 4 | PF00743 | |
| Domain | Flavin_mOase | 2.29e-09 | 5 | 88 | 4 | IPR000960 | |
| Domain | Flavin_mOase-like | 2.29e-09 | 5 | 88 | 4 | IPR020946 | |
| Domain | DiMe-aniline_mOase | 2.29e-09 | 5 | 88 | 4 | IPR012143 | |
| Domain | P-type_ATPase_IIA | 1.01e-07 | 3 | 88 | 3 | IPR005782 | |
| Domain | KH_1 | 9.19e-07 | 38 | 88 | 5 | PF00013 | |
| Domain | - | 1.05e-06 | 39 | 88 | 5 | 3.30.1370.10 | |
| Domain | KH | 1.20e-06 | 40 | 88 | 5 | SM00322 | |
| Domain | KH_dom | 1.20e-06 | 40 | 88 | 5 | IPR004087 | |
| Domain | KH_TYPE_1 | 1.53e-06 | 42 | 88 | 5 | PS50084 | |
| Domain | KH_dom_type_1 | 1.95e-06 | 44 | 88 | 5 | IPR004088 | |
| Domain | IG_FLMN | 1.18e-05 | 10 | 88 | 3 | SM00557 | |
| Domain | Hydrolase_3 | 1.18e-05 | 10 | 88 | 3 | PF08282 | |
| Domain | Filamin | 1.62e-05 | 11 | 88 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.62e-05 | 11 | 88 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.62e-05 | 11 | 88 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.62e-05 | 11 | 88 | 3 | IPR017868 | |
| Domain | Ral | 2.19e-05 | 2 | 88 | 2 | IPR028412 | |
| Domain | - | 5.41e-05 | 16 | 88 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 5.41e-05 | 16 | 88 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.55e-05 | 17 | 88 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 6.55e-05 | 17 | 88 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 7.84e-05 | 18 | 88 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 7.84e-05 | 18 | 88 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 9.27e-05 | 19 | 88 | 3 | IPR004014 | |
| Domain | - | 1.40e-04 | 56 | 88 | 4 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 1.50e-04 | 57 | 88 | 4 | IPR023753 | |
| Domain | P-loop_NTPase | RALA RALB TPST1 TRANK1 KIF26A ABCB5 DDX42 MAGI3 ABCC2 POLQ RAB1A DICER1 GSPT1 | 1.63e-04 | 848 | 88 | 13 | IPR027417 |
| Domain | - | 4.54e-04 | 32 | 88 | 3 | 3.40.1110.10 | |
| Domain | - | 4.54e-04 | 32 | 88 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 5.93e-04 | 35 | 88 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 6.45e-04 | 36 | 88 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 6.45e-04 | 36 | 88 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 6.45e-04 | 36 | 88 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.99e-04 | 37 | 88 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.99e-04 | 37 | 88 | 3 | PF00122 | |
| Domain | - | RALA RALB TPST1 TRANK1 ABCB5 DDX42 ABCC2 POLQ RAB1A DICER1 GSPT1 | 7.46e-04 | 746 | 88 | 11 | 3.40.50.300 |
| Domain | Ig_E-set | 1.48e-03 | 104 | 88 | 4 | IPR014756 | |
| Domain | - | 3.20e-03 | 18 | 88 | 2 | 3.30.470.20 | |
| Domain | CH | 3.58e-03 | 65 | 88 | 3 | SM00033 | |
| Domain | CH | 4.41e-03 | 70 | 88 | 3 | PF00307 | |
| Domain | - | 4.59e-03 | 71 | 88 | 3 | 1.10.418.10 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.96e-03 | 73 | 88 | 3 | IPR011545 | |
| Domain | CH | 4.96e-03 | 73 | 88 | 3 | PS50021 | |
| Domain | DEAD | 4.96e-03 | 73 | 88 | 3 | PF00270 | |
| Domain | Actinin_actin-bd_CS | 5.21e-03 | 23 | 88 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 5.21e-03 | 23 | 88 | 2 | PS00020 | |
| Domain | ACTININ_1 | 5.21e-03 | 23 | 88 | 2 | PS00019 | |
| Pathway | WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS | 3.48e-09 | 5 | 74 | 4 | M39449 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 7.63e-06 | 8 | 74 | 3 | M47955 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | UNC119 SYNJ1 ACLY CSNK1G2 CYP51A1 CYB5R3 SCP2 HEATR5B RAB1A FABP4 | 2.84e-05 | 381 | 74 | 10 | M48063 |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.95e-05 | 12 | 74 | 3 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 4.85e-05 | 14 | 74 | 3 | MM15052 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.07e-04 | 18 | 74 | 3 | M614 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.81e-04 | 54 | 74 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.81e-04 | 54 | 74 | 4 | MM15202 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.19e-04 | 176 | 74 | 6 | MM15718 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.39e-04 | 178 | 74 | 6 | M2890 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.71e-04 | 27 | 74 | 3 | MM15053 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.93e-04 | 183 | 74 | 6 | M997 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_TERMINATION | 4.02e-04 | 6 | 74 | 2 | MM15419 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.14e-04 | 28 | 74 | 3 | M924 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 5.09e-04 | 30 | 74 | 3 | M76 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 5.50e-04 | 72 | 74 | 4 | M9257 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 7.46e-04 | 8 | 74 | 2 | M26991 | |
| Pubmed | 6.21e-13 | 6 | 90 | 5 | 12527699 | ||
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 8128486 | ||
| Pubmed | Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine. | 2.09e-10 | 5 | 90 | 4 | 32156684 | |
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 8311461 | ||
| Pubmed | VIL1 RALA RALB FLNA FLNC INTU ACACB KHDRBS1 ABCB5 DDX42 CYB5R3 MAGI3 ABCC2 POLQ RAB1A ATP2A1 ATP2A2 ATP2A3 RYR2 GSPT1 | 6.31e-10 | 1442 | 90 | 20 | 35575683 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.91e-09 | 8 | 90 | 4 | 19033399 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 11551524 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 16410239 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 6.69e-08 | 4 | 90 | 3 | 10362770 | |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 25110346 | ||
| Pubmed | Quantitative analysis of FMO gene mRNA levels in human tissues. | 6.69e-08 | 4 | 90 | 3 | 16183778 | |
| Pubmed | The molecular biology of the flavin-containing monooxygenases of man. | 6.69e-08 | 4 | 90 | 3 | 7720101 | |
| Pubmed | RALA FLNA DIP2A FLNC ASRGL1 KHDRBS1 SYNJ1 GAPDH ACLY RAPGEF4 SRCIN1 SPECC1L ARHGEF11 RAB1A ATP2A2 METAP2 SNTA1 | 1.37e-07 | 1431 | 90 | 17 | 37142655 | |
| Pubmed | KSR1 XIRP1 SYNJ1 DSG2 USHBP1 CSNK1G2 APEH SRCIN1 GPT2 RBM34 PLIN2 OTUD7B | 2.22e-07 | 689 | 90 | 12 | 36543142 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RALA FLNA FLNC KHDRBS1 GAPDH DSG2 ACLY DDX42 SPECC1L HEATR5B RAB1A ATP2A2 DICER1 SF1 | 3.81e-07 | 1024 | 90 | 14 | 24711643 |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 5.82e-07 | 7 | 90 | 3 | 24786561 | |
| Pubmed | 8.18e-07 | 66 | 90 | 5 | 19898482 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 8.46e-07 | 392 | 90 | 9 | 33144569 | |
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 10951186 | ||
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 11784029 | ||
| Pubmed | Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. | 9.30e-07 | 8 | 90 | 3 | 27923914 | |
| Pubmed | 1.09e-06 | 30 | 90 | 4 | 20529763 | ||
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 1.39e-06 | 9 | 90 | 3 | 25640239 | |
| Pubmed | KSR1 FLNA KHDRBS1 GAPDH ACLY CSNK1G2 ALG5 CYP51A1 DDX42 CYB5R3 SCP2 HSD11B1 HEATR5B ADCY3 | 1.80e-06 | 1168 | 90 | 14 | 19946888 | |
| Pubmed | FLNA PCBP3 KHDRBS1 GAPDH DSG2 ACLY CYP51A1 TRUB1 HEATR5B RAB1A ATP2A2 GSPT1 | 2.80e-06 | 878 | 90 | 12 | 37223481 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.89e-06 | 38 | 90 | 4 | 30786075 | |
| Pubmed | 3.03e-06 | 341 | 90 | 8 | 29791485 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 4.21e-06 | 477 | 90 | 9 | 31300519 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DIP2A TRANK1 ACACB COL6A6 RAPGEF4 SRCIN1 ARHGEF11 ATP2A3 RBM34 | 5.86e-06 | 497 | 90 | 9 | 36774506 |
| Pubmed | 6.45e-06 | 503 | 90 | 9 | 36217030 | ||
| Pubmed | Ral GTPases in Schwann cells promote radial axonal sorting in the peripheral nervous system. | 6.62e-06 | 2 | 90 | 2 | 31201267 | |
| Pubmed | RalGTPases contribute to Schwann cell repair after nerve injury via regulation of process formation. | 6.62e-06 | 2 | 90 | 2 | 31201266 | |
| Pubmed | RalA and RalB differentially regulate development of epithelial tight junctions. | 6.62e-06 | 2 | 90 | 2 | 22013078 | |
| Pubmed | Differential involvement of RalA and RalB in colorectal cancer. | 6.62e-06 | 2 | 90 | 2 | 22790202 | |
| Pubmed | Ral GTPases regulate cell-mediated cytotoxicity in NK cells. | 6.62e-06 | 2 | 90 | 2 | 21810610 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12556521 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11025226 | ||
| Pubmed | RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis. | 6.62e-06 | 2 | 90 | 2 | 34096503 | |
| Pubmed | RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. | 6.62e-06 | 2 | 90 | 2 | 12856001 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25270119 | ||
| Pubmed | Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. | 6.62e-06 | 2 | 90 | 2 | 11242047 | |
| Pubmed | Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction. | 6.62e-06 | 2 | 90 | 2 | 26523449 | |
| Pubmed | Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver. | 6.62e-06 | 2 | 90 | 2 | 1542660 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19644701 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26216878 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23830877 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 6.62e-06 | 2 | 90 | 2 | 14638697 | |
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. | 6.62e-06 | 2 | 90 | 2 | 10603953 | |
| Pubmed | Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight. | 6.62e-06 | 2 | 90 | 2 | 34769190 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18295663 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19650915 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18953100 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 7689010 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22700969 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 2662142 | ||
| Pubmed | SERCA overexpression reduces hydroxyl radical injury in murine myocardium. | 6.62e-06 | 2 | 90 | 2 | 16798816 | |
| Pubmed | Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. | 6.62e-06 | 2 | 90 | 2 | 17174914 | |
| Pubmed | Identification of a novel human member of the DEAD box protein family. | 6.62e-06 | 2 | 90 | 2 | 10727850 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20679536 | ||
| Pubmed | ASIC1/RIP1 accelerates atherosclerosis via disrupting lipophagy. | 6.62e-06 | 2 | 90 | 2 | 37931656 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21885870 | ||
| Pubmed | Localization of human flavin-containing monooxygenase genes FMO2 and FMO5 to chromosome 1q. | 6.62e-06 | 2 | 90 | 2 | 8786146 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19962989 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 37115197 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10679933 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20716843 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 1417778 | ||
| Pubmed | Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. | 6.62e-06 | 2 | 90 | 2 | 18756269 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17875936 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12975374 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15718407 | ||
| Pubmed | Expression of ral GTPases, their effectors, and activators in human bladder cancer. | 6.62e-06 | 2 | 90 | 2 | 17606711 | |
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 6.62e-06 | 2 | 90 | 2 | 24469451 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11402072 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 7.91e-06 | 516 | 90 | 9 | 36610398 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 9.21e-06 | 283 | 90 | 7 | 28533407 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNA FLNC KHDRBS1 GAPDH DSG2 CYP51A1 CYB5R3 SCP2 APEH RAB1A ATP2A2 METAP2 SF1 GSPT1 | 1.09e-05 | 1367 | 90 | 14 | 32687490 |
| Pubmed | 1.11e-05 | 17 | 90 | 3 | 14741744 | ||
| Pubmed | VIL1 RALA FLNA GAPDH DSG2 ACLY CYB5R3 SPECC1L TRUB1 RAB1A METAP2 DICER1 SF1 RBM34 | 1.12e-05 | 1371 | 90 | 14 | 36244648 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FLNA FLNC GAPDH DSG2 ALG5 CYP51A1 DDX42 CYB5R3 GPATCH8 RAB1A ATP2A2 SF1 NOVA2 | 1.32e-05 | 1203 | 90 | 13 | 29180619 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RALA FLNA KHDRBS1 GAPDH DSG2 ACLY DDX42 CYB5R3 RAB1A ATP2A2 DICER1 SF1 RBM34 GSPT1 | 1.73e-05 | 1425 | 90 | 14 | 30948266 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.84e-05 | 724 | 90 | 10 | 36232890 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11252955 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 12704190 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 19843512 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 28817177 | ||
| Pubmed | Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. | 1.98e-05 | 3 | 90 | 2 | 27055500 | |
| Pubmed | Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage. | 1.98e-05 | 3 | 90 | 2 | 27206985 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 7473608 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 24792439 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 25615793 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11038172 | ||
| Pubmed | Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma. | 1.98e-05 | 3 | 90 | 2 | 34009715 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 9788433 | ||
| Pubmed | Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5. | 1.98e-05 | 3 | 90 | 2 | 17721934 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23063435 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 16973504 | ||
| Pubmed | Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice. | 1.98e-05 | 3 | 90 | 2 | 19419309 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11526231 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23115302 | ||
| Interaction | FMO5 interactions | 3.31e-10 | 10 | 87 | 5 | int:FMO5 | |
| Interaction | FMO2 interactions | 4.02e-08 | 9 | 87 | 4 | int:FMO2 | |
| Interaction | PRNP interactions | RALA KSR1 FLNA FLNC XIRP1 ASRGL1 TRIM2 SYNJ1 DSG2 USHBP1 CSNK1G2 CYB5R3 APEH SRCIN1 IRGQ GPT2 SNTA1 RBM34 PLIN2 OTUD7B | 7.78e-08 | 1158 | 87 | 20 | int:PRNP |
| Interaction | FMO4 interactions | 2.69e-06 | 7 | 87 | 3 | int:FMO4 | |
| Interaction | CCDC8 interactions | RALA FLNA TDRKH KHDRBS1 GAPDH DSG2 ACLY SPECC1L HEATR5B RAB1A ATP2A2 DICER1 SF1 | 4.57e-06 | 656 | 87 | 13 | int:CCDC8 |
| Interaction | FMO3 interactions | 6.41e-06 | 9 | 87 | 3 | int:FMO3 | |
| Interaction | SHANK3 interactions | RALA FLNA KHDRBS1 SYNJ1 GAPDH ACLY CYP51A1 RAPGEF4 CYB5R3 GRID2 ABCC2 | 9.32e-06 | 496 | 87 | 11 | int:SHANK3 |
| Interaction | OSTF1 interactions | 4.40e-05 | 90 | 87 | 5 | int:OSTF1 | |
| Interaction | PPP1R9B interactions | FLNA ASRGL1 SYNJ1 GAPDH ACLY CYP51A1 RAPGEF4 SRCIN1 ARHGEF11 RAB1A ATP2A2 | 7.83e-05 | 626 | 87 | 11 | int:PPP1R9B |
| Interaction | KCTD13 interactions | RALA FLNA DIP2A FLNC ASRGL1 KHDRBS1 SYNJ1 GAPDH ACLY RAPGEF4 SRCIN1 SPECC1L ARHGEF11 RAB1A ATP2A2 METAP2 SNTA1 | 8.29e-05 | 1394 | 87 | 17 | int:KCTD13 |
| Cytoband | 1q24.3 | 6.53e-08 | 20 | 90 | 4 | 1q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q24 | 1.26e-04 | 129 | 90 | 4 | chr1q24 | |
| Cytoband | 3p22.2 | 1.02e-03 | 24 | 90 | 2 | 3p22.2 | |
| Cytoband | 1p32 | 1.29e-03 | 27 | 90 | 2 | 1p32 | |
| Cytoband | 12q24.11 | 1.93e-03 | 33 | 90 | 2 | 12q24.11 | |
| GeneFamily | ATPases Ca2+ transporting | 1.86e-06 | 9 | 52 | 3 | 1209 | |
| GeneFamily | PDZ domain containing | 9.50e-04 | 152 | 52 | 4 | 1220 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.68e-09 | 197 | 90 | 8 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-07 | 111 | 90 | 6 | 9ba3590be8862c23b6e2917caed8bdbd9f9c2753 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-07 | 111 | 90 | 6 | 3e38efb22c47506ef2e2c1e19c79450e11d0ce56 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-07 | 111 | 90 | 6 | cd84f2a9102a6eb63226ecde11d4ece54ff99b48 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 181 | 90 | 6 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-06 | 189 | 90 | 6 | 2e43428f1ef9683c6f8c9897d46aa7d34bf9047f | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-06 | 190 | 90 | 6 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 191 | 90 | 6 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 192 | 90 | 6 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 195 | 90 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 3.08e-06 | 198 | 90 | 6 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 154 | 90 | 5 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 154 | 90 | 5 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.90e-05 | 161 | 90 | 5 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.20e-05 | 166 | 90 | 5 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 2.39e-05 | 169 | 90 | 5 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | COVID-19_Mild-PLT_3|COVID-19_Mild / Disease Group and Platelet Clusters | 2.46e-05 | 170 | 90 | 5 | 5ac1252ae3c026a506cfe26e3d119276fe364661 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 175 | 90 | 5 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 177 | 90 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 177 | 90 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.15e-05 | 179 | 90 | 5 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | f9b7d5eb7b6ea72253c89bdc351ad2b4a53f7d8e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 180 | 90 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | 53db6032eda0e590ae7e01c9c3b472785ea6782f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | 28bc10b9d0e4430b952260014d8a6ff337860ac6 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.24e-05 | 180 | 90 | 5 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 180 | 90 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 92 | 90 | 4 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 92 | 90 | 4 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 92 | 90 | 4 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.69e-05 | 185 | 90 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 186 | 90 | 5 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 186 | 90 | 5 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 187 | 90 | 5 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 187 | 90 | 5 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 187 | 90 | 5 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.51e-05 | 193 | 90 | 5 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.51e-05 | 193 | 90 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 193 | 90 | 5 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 194 | 90 | 5 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 194 | 90 | 5 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 194 | 90 | 5 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 195 | 90 | 5 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 195 | 90 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.74e-05 | 195 | 90 | 5 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 199 | 90 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 199 | 90 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 90 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.34e-05 | 200 | 90 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.34e-05 | 200 | 90 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 131 | 90 | 4 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 139 | 90 | 4 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 139 | 90 | 4 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | Control-PLT_3|Control / Disease Group and Platelet Clusters | 1.86e-04 | 140 | 90 | 4 | 82ea671f61d55f6896d903c5876b042e2f3385d6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 142 | 90 | 4 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 142 | 90 | 4 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 146 | 90 | 4 | d903e091a917d3f5dcf82107e636520f75e47403 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 146 | 90 | 4 | 9c9218e5257253597f2fd74fbd589b962d3078a3 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 156 | 90 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | control-B_cell|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.89e-04 | 157 | 90 | 4 | 1269b55f2ef6a493f6116b131cc5cc7b8897d63e | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-04 | 158 | 90 | 4 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 161 | 90 | 4 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.49e-04 | 165 | 90 | 4 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.57e-04 | 166 | 90 | 4 | a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.57e-04 | 166 | 90 | 4 | c64971c27cb445dffc5a636d4b6a60261b93a2db | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 166 | 90 | 4 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.57e-04 | 166 | 90 | 4 | 6210a136efb99d70c2026b6454363f1bd2723558 | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.57e-04 | 166 | 90 | 4 | 2f3072a7af048f184d33065fdd36153fd563155a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 166 | 90 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 166 | 90 | 4 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.57e-04 | 166 | 90 | 4 | 188f2575511f418216874aed9118aa6f165252cb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-04 | 167 | 90 | 4 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.65e-04 | 167 | 90 | 4 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-04 | 168 | 90 | 4 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 168 | 90 | 4 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 168 | 90 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-04 | 168 | 90 | 4 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 168 | 90 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 169 | 90 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 169 | 90 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 169 | 90 | 4 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.82e-04 | 169 | 90 | 4 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 170 | 90 | 4 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 170 | 90 | 4 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 170 | 90 | 4 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-04 | 171 | 90 | 4 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| Computational | Small monomeric GTPases. | 1.11e-04 | 43 | 63 | 4 | MODULE_86 | |
| Drug | N,N-dimethylaniline-N-oxide | 3.69e-10 | 11 | 89 | 5 | CID000000950 | |
| Drug | Ccris 2188 | 1.09e-09 | 5 | 89 | 4 | CID000146896 | |
| Drug | AC1L380G | 9.07e-09 | 19 | 89 | 5 | CID000084698 | |
| Drug | 1,2-dithiol-3-thione | UNC119 FLNC GAPDH ACLY CYP51A1 RAPGEF4 DDX42 CYB5R3 NFYB SCP2 RAB1A ATP2A1 ATP2A2 METAP2 GSPT1 PLIN2 | 1.21e-07 | 829 | 89 | 16 | ctd:C049325 |
| Drug | methyl p-tolyl sulfide | 2.12e-07 | 14 | 89 | 4 | CID000069334 | |
| Drug | mag-fura-2 | 3.22e-07 | 37 | 89 | 5 | CID000123839 | |
| Drug | N,N-dimethylaniline | 6.18e-07 | 42 | 89 | 5 | CID000000949 | |
| Drug | benzo(c)fluorene | 1.15e-06 | 6 | 89 | 3 | CID000009150 | |
| Drug | benzydamine N-oxide | 2.00e-06 | 7 | 89 | 3 | CID000065465 | |
| Drug | S-benzyl-L-cysteine | 2.18e-06 | 24 | 89 | 4 | CID000076454 | |
| Drug | trimethylamine | 2.43e-06 | 55 | 89 | 5 | CID000001146 | |
| Drug | dodecyl ether | 3.05e-06 | 26 | 89 | 4 | CID000020667 | |
| Drug | thiobenzamide | 3.05e-06 | 26 | 89 | 4 | CID000683563 | |
| Drug | Therarubicin | 3.76e-06 | 60 | 89 | 5 | CID000004844 | |
| Drug | 2-butenedioate | 3.81e-06 | 234 | 89 | 8 | CID000000723 | |
| Drug | senkirkine | 4.08e-06 | 61 | 89 | 5 | ctd:C009238 | |
| Drug | hydride | FMO2 FMO3 FMO4 FMO5 GAPDH ASIC1 CYP51A1 CYB5R3 TNNC2 HSD11B1 ATP2A1 ATP2A2 ATP2A3 SLC1A6 | 4.24e-06 | 835 | 89 | 14 | CID000000783 |
| Drug | TCVC | 4.77e-06 | 9 | 89 | 3 | CID000108091 | |
| Drug | octaethylene glycol | 4.81e-06 | 29 | 89 | 4 | CID000078798 | |
| Drug | N-ethylmaleimide | INTU XIRP1 ABCB5 ABCC2 POLQ RAB1A ATP2A1 ATP2A2 ATP2A3 ADCY3 SMG6 | 4.93e-06 | 511 | 89 | 11 | CID000004362 |
| Drug | Pyrrolizidine Alkaloids | 6.03e-06 | 66 | 89 | 5 | ctd:D011763 | |
| Drug | epicholesterol | ACLY ABCB5 CYP51A1 SCP2 ABCC2 GPT2 ATP2A1 ATP2A2 ATP2A3 ADCY3 FABP4 PLIN2 | 6.79e-06 | 636 | 89 | 12 | CID000000304 |
| Drug | ATP-EDC | 6.79e-06 | 10 | 89 | 3 | CID000195647 | |
| Drug | 1sqc | 6.79e-06 | 10 | 89 | 3 | CID000444279 | |
| Drug | strontium | 6.99e-06 | 68 | 89 | 5 | CID000104798 | |
| Drug | fluo-3 | 8.45e-06 | 122 | 89 | 6 | CID000104978 | |
| Drug | 2,5-dimethylquinone | 9.31e-06 | 11 | 89 | 3 | CID000008718 | |
| Drug | RA-V | 1.04e-05 | 35 | 89 | 4 | CID000476891 | |
| Drug | senecionine | 1.06e-05 | 74 | 89 | 5 | ctd:C009237 | |
| Drug | p-tolyl sulfoxide | 1.24e-05 | 12 | 89 | 3 | CID000015680 | |
| Drug | 1vyq | 1.24e-05 | 12 | 89 | 3 | CID004369390 | |
| Drug | K-Cl | KSR1 GAPDH CSNK1G2 TNNC2 POLQ ATP2A1 ATP2A2 ATP2A3 ADCY3 RYR2 SMG6 | 1.31e-05 | 567 | 89 | 11 | CID000004873 |
| Drug | Chlorine | 1.36e-05 | 367 | 89 | 9 | ctd:D002713 | |
| Drug | hydroxyl radicals | ASRGL1 FMO2 FMO3 FMO4 FMO5 SYNJ1 GAPDH TPTE2 CYP51A1 SRCIN1 HSD11B1 TRUB1 ATP2A1 ATP2A2 ATP2A3 FMO6P FABP4 | 1.49e-05 | 1341 | 89 | 17 | CID000000961 |
| Drug | lanthanum | 1.57e-05 | 136 | 89 | 6 | CID000023926 | |
| Drug | daunorubicin semiquinone | 1.61e-05 | 285 | 89 | 8 | CID000002958 | |
| Drug | n-octylamine | 1.62e-05 | 39 | 89 | 4 | CID000008143 | |
| Drug | XeC compound | 1.97e-05 | 84 | 89 | 5 | CID000005701 | |
| Drug | p-hydroxyhippuric acid | 2.04e-05 | 14 | 89 | 3 | CID000151012 | |
| Drug | C12E8 | 2.18e-05 | 42 | 89 | 4 | CID000123921 | |
| Drug | nimodipine | 2.26e-05 | 145 | 89 | 6 | CID000004497 | |
| Drug | NSC239129 | 2.54e-05 | 15 | 89 | 3 | CID000084597 | |
| Drug | phenothiazine | 2.63e-05 | 44 | 89 | 4 | CID000007108 | |
| Drug | amsacrine | 2.88e-05 | 45 | 89 | 4 | CID000002179 | |
| Drug | Bezafibrate | 3.25e-05 | 229 | 89 | 7 | ctd:D001629 | |
| Drug | CaCl2 | 3.42e-05 | 156 | 89 | 6 | CID000024854 | |
| Drug | tauroursodeoxycholic acid | 3.54e-05 | 157 | 89 | 6 | ctd:C031655 | |
| Drug | heliotrine | 3.72e-05 | 48 | 89 | 4 | ctd:C010178 | |
| Drug | beta-Glucans | 3.77e-05 | 17 | 89 | 3 | ctd:D047071 | |
| Drug | AC1L88YH | 3.77e-05 | 17 | 89 | 3 | CID000374551 | |
| Drug | calmidazolium chloride | 3.94e-05 | 160 | 89 | 6 | CID000002531 | |
| Drug | indo-1 | 4.36e-05 | 99 | 89 | 5 | CID000105060 | |
| Drug | butyl p-tolyl sulfide | 4.52e-05 | 3 | 89 | 2 | CID000304040 | |
| Drug | NSC381866 | 5.34e-05 | 169 | 89 | 6 | CID000002287 | |
| Drug | oleoyl-estrone | 6.39e-05 | 55 | 89 | 4 | ctd:C108709 | |
| Drug | K-K-K | 6.49e-05 | 175 | 89 | 6 | CID000003823 | |
| Drug | TMB-8 | 6.69e-05 | 176 | 89 | 6 | CID000005494 | |
| Drug | AC1NSKPI | 7.36e-05 | 57 | 89 | 4 | CID005311482 | |
| Drug | cisapride | 7.87e-05 | 112 | 89 | 5 | CID000002769 | |
| Drug | Fatty Acids, Essential | 8.42e-05 | 59 | 89 | 4 | ctd:D005228 | |
| Drug | AC1NRA3U | 8.43e-05 | 22 | 89 | 3 | CID005287684 | |
| Drug | benzydamine | 8.43e-05 | 22 | 89 | 3 | CID000012555 | |
| Drug | 3,5-dihydroxyphenylglycine | 9.00e-05 | 60 | 89 | 4 | CID000108001 | |
| Drug | Benzydamine | 9.02e-05 | 4 | 89 | 2 | ctd:D001591 | |
| Drug | ranitidine N-oxide | 9.02e-05 | 4 | 89 | 2 | CID003033888 | |
| Drug | AC1L25Y6 | 9.66e-05 | 23 | 89 | 3 | CID000015465 | |
| Drug | divicine | 9.66e-05 | 23 | 89 | 3 | CID000091606 | |
| Drug | lanthanum chloride hydrate | 9.66e-05 | 23 | 89 | 3 | CID000165791 | |
| Drug | TCNB | 1.05e-04 | 119 | 89 | 5 | CID000008330 | |
| Drug | Spermine | 1.09e-04 | 63 | 89 | 4 | ctd:D013096 | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 2884_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 7470_UP | |
| Drug | Clofibric Acid | ASRGL1 FMO3 TRIM2 MRPL16 RAPGEF4 CYB5R3 SCP2 HSD11B1 ABCC2 FABP4 PLIN2 | 1.24e-04 | 727 | 89 | 11 | ctd:D002995 |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 4977_DN | |
| Drug | EUK-8 | 1.25e-04 | 25 | 89 | 3 | CID000171249 | |
| Drug | cyhexatin | 1.25e-04 | 25 | 89 | 3 | CID005364545 | |
| Drug | acyclovir | 1.27e-04 | 124 | 89 | 5 | CID000002022 | |
| Drug | beta-NADP | 1.27e-04 | 490 | 89 | 9 | CID000000929 | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 2242_UP | |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.35e-04 | 200 | 89 | 6 | 5632_DN | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 1.35e-04 | 200 | 89 | 6 | 5700_UP | |
| Drug | bepridil | 1.37e-04 | 126 | 89 | 5 | CID000002351 | |
| Drug | methimazole | 1.37e-04 | 126 | 89 | 5 | CID001349907 | |
| Drug | chlordecone | 1.39e-04 | 67 | 89 | 4 | CID000000299 | |
| Drug | AC1LCV0Y | 1.41e-04 | 26 | 89 | 3 | CID000656469 | |
| Drug | thiodicarb | 1.50e-04 | 5 | 89 | 2 | CID000062155 | |
| Drug | tBuBHQ | 1.55e-04 | 69 | 89 | 4 | CID000002374 | |
| Drug | AC1L1IZE | 1.65e-04 | 131 | 89 | 5 | CID000004799 | |
| Drug | rhod-2 | 1.76e-04 | 28 | 89 | 3 | CID000123669 | |
| Drug | T-I-Q | 1.76e-04 | 28 | 89 | 3 | CID000039062 | |
| Drug | cocaethylene | 1.93e-04 | 73 | 89 | 4 | CID000002825 | |
| Drug | sodium cholate | 1.98e-04 | 408 | 89 | 8 | CID000000303 | |
| Drug | carbamate | 2.04e-04 | 74 | 89 | 4 | CID000000276 | |
| Drug | Cholic Acid | 2.15e-04 | 75 | 89 | 4 | ctd:D019826 | |
| Drug | NADP(H | 2.19e-04 | 527 | 89 | 9 | CID000000930 | |
| Drug | N-ethyl-N-methylaniline | 2.24e-04 | 6 | 89 | 2 | CID000011956 | |
| Drug | bisphenol A glucuronide | 2.24e-04 | 6 | 89 | 2 | ctd:C512161 | |
| Drug | v 104 | 2.24e-04 | 6 | 89 | 2 | CID000107262 | |
| Drug | halothane | 2.33e-04 | 314 | 89 | 7 | CID000003562 | |
| Drug | L-methionine sulfoxide | 2.37e-04 | 77 | 89 | 4 | CID000000847 | |
| Disease | Brody myopathy (implicated_via_orthology) | 2.65e-08 | 3 | 89 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 5.28e-06 | 38 | 89 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | S-methylcysteine measurement | 9.00e-06 | 2 | 89 | 2 | EFO_0800054 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.69e-05 | 3 | 89 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.69e-05 | 3 | 89 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Petit mal status | 5.13e-05 | 67 | 89 | 4 | C0270823 | |
| Disease | Grand Mal Status Epilepticus | 5.13e-05 | 67 | 89 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 5.13e-05 | 67 | 89 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 5.13e-05 | 67 | 89 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 5.13e-05 | 67 | 89 | 4 | C0751523 | |
| Disease | Complex Partial Status Epilepticus | 5.13e-05 | 67 | 89 | 4 | C0393734 | |
| Disease | Status Epilepticus | 5.43e-05 | 68 | 89 | 4 | C0038220 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.50e-05 | 147 | 89 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | COVID-19, obesity | 1.87e-04 | 7 | 89 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | Obesity | 3.99e-04 | 205 | 89 | 5 | C0028754 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 4.86e-04 | 11 | 89 | 2 | C1335302 | |
| Disease | Diabetic Cardiomyopathies | 4.86e-04 | 11 | 89 | 2 | C0853897 | |
| Disease | Methionine sulfoxide measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0021650 | |
| Disease | niacinamide measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0010511 | |
| Disease | lentiform nucleus measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0004913 | |
| Disease | Cannabis use | 1.05e-03 | 16 | 89 | 2 | EFO_0007585 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.33e-03 | 18 | 89 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | essential hypertension (is_implicated_in) | 1.33e-03 | 18 | 89 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.82e-03 | 21 | 89 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | xanthosine measurement | 2.58e-03 | 25 | 89 | 2 | EFO_0010549 | |
| Disease | revision of total knee arthroplasty | 2.79e-03 | 26 | 89 | 2 | EFO_0020972 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MIGKAGGVSLSKVER | 271 | O60507 | |
| GSRTDKKMDGGSGRE | 66 | Q8N6Y0 | |
| KILVSGGGKSRTGVM | 196 | Q8TD30 | |
| KGKRMGKGEGVRETH | 216 | Q86US8 | |
| TGGIVNKMVGRVGDS | 186 | Q7L266 | |
| TLVGEKGAQMSGGQK | 516 | Q2M3G0 | |
| TLVKNRGKGGAIRMG | 136 | Q9Y673 | |
| SVRPGGAAMKAGVKE | 71 | O15085 | |
| VGVDISGRFMTSGKK | 156 | Q9C0F1 | |
| GMAGGVTVTNGVKGK | 61 | Q69YQ0 | |
| KVIVTGASKGIGREM | 36 | P28845 | |
| TVEVVGKGKFKGVGR | 1881 | Q9UPY3 | |
| LKKAEIGIAMGSGTA | 711 | O14983 | |
| LKKAEIGIAMGSGTA | 711 | Q93084 | |
| KVIMVGSGGVGKSAL | 16 | P11233 | |
| KVIMVGSGGVGKSAL | 16 | P11234 | |
| EIKKRMGPGATAGGA | 171 | P62820 | |
| VRIVRDKMTGIGKGF | 316 | P42696 | |
| TVKSVGMIAGGTGIT | 171 | P00387 | |
| LMIKASEGGGGKGIR | 451 | O00763 | |
| LVGRNGVGGMAKEAT | 681 | Q14126 | |
| KEAERKIMNGGIGGG | 646 | Q6GQQ9 | |
| MGKKVAIIGAGVSGL | 1 | P31513 | |
| GKTVPIVKGGEATRM | 341 | P50579 | |
| SGNKVTGTIGMAEKR | 1466 | Q5TCQ9 | |
| KGGKGETEEGRRMSK | 6 | P78368 | |
| RDMIGIAKTGSGKTA | 291 | Q86XP3 | |
| EVGGEKIVRSSGGRM | 616 | Q9UKJ3 | |
| GRSMLETIKKGGVSG | 366 | O43424 | |
| GVGIATVMGKIFAVG | 546 | Q9P2G9 | |
| GEGMKRVLTSVSLGK | 836 | Q8IVT5 | |
| VMRVGTGGIVGSKGD | 66 | A0A0B4J1Y8 | |
| KTVMGIGSGGERAKA | 221 | Q9H340 | |
| GSPFTVKVTGEGRMK | 2121 | Q14315 | |
| MAKKVAVIGAGVSGL | 1 | P31512 | |
| FREAMKGEKGIGGAV | 141 | P25208 | |
| AKAGRGTVMGTKQAL | 1546 | Q9ULI4 | |
| SMEKIGVVGRTGAGK | 1326 | Q92887 | |
| MSKRVGIIGAGVSGL | 1 | O60774 | |
| IGKGGATVKAVMEQS | 146 | Q9UNW9 | |
| KDMGTVVLGKLESGS | 311 | P15170 | |
| LMHGKEVGSIIGKKG | 51 | P57721 | |
| GGSAMKSGQVLIGDV | 216 | Q9ULD6 | |
| KKAEIGIAMGSGTAV | 711 | P16615 | |
| LKSGGEMLKVGGSVN | 286 | Q9P2D3 | |
| KGEITGEVRMPSGKV | 1801 | P21333 | |
| MTKKRIAVIGGGVSG | 1 | P49326 | |
| QMVGRAGRKGVDTVG | 476 | O75417 | |
| GGSVLGQAMEKVTGG | 16 | Q16850 | |
| RIGMNKGGVLAGVIG | 1041 | O60266 | |
| VAFGLVIGGMKHKGR | 276 | P48664 | |
| MAKKVAVIGAGVSGL | 1 | Q99518 | |
| TGAKISVLGKGSMRD | 191 | Q07666 | |
| MKEVGVGFATRKVAG | 21 | P15090 | |
| KGLGAQTGVLRMKGV | 1256 | Q14689 | |
| GGNELGMGKVKEAVR | 481 | Q7Z3D6 | |
| GVRKEVDGMGTSEIK | 341 | Q92736 | |
| GETGLKGARGKMISA | 1686 | A6NMZ7 | |
| SEGLQQVVGMKKSGG | 391 | Q8WZA9 | |
| QVVGMKKSGGGDSER | 396 | Q8WZA9 | |
| ITRKSVGHRMGGGKG | 131 | Q9NX20 | |
| GEGLIIVKMSSGGEK | 706 | Q8WZA2 | |
| GGLGISIKGGRENKM | 96 | Q13424 | |
| SREGGKGKEMNGRVS | 361 | P32745 | |
| RDVAVDTVKTGMGGA | 651 | O43426 | |
| DTVKTGMGGATGNKG | 656 | O43426 | |
| MGKVKVGVNGFGRIG | 1 | P04406 | |
| GEGKKARVMATIGVT | 366 | Q5JR12 | |
| VMREGIKGATVGKLA | 636 | Q13546 | |
| VVGVGMTKFVKPGAE | 16 | P22307 | |
| TMKAVLRKAGGTGPG | 101 | P13798 | |
| EGLRVMGEVGKTTGI | 386 | P53396 | |
| RLKTMKGGTGNGLEI | 206 | P78348 | |
| ESGKGKGIAGREEMT | 136 | P59282 | |
| VIRKGGVASGMKHVE | 116 | P09327 | |
| MKVKKGGGGAGTATE | 1 | Q13432 | |
| KGGGDMAVVVSKEGS | 256 | Q9Y2W6 | |
| ASKAGGMVLVKGEGL | 381 | Q9C0H9 | |
| GMKVLQKVTRGRTAG | 551 | Q14159 | |
| QMELKTGKGAGERAG | 791 | O94964 | |
| AGNGTGAGLVMKVKQ | 6 | Q96BV0 | |
| RRLGMGEGGVSKLKS | 521 | Q9Y6S9 | |
| GGGDISVKELGTVMR | 31 | P02585 | |
| AKGVISGVGKGIMGV | 3791 | Q7Z7G8 | |
| SGVGKGIMGVFTKPI | 3796 | Q7Z7G8 | |
| GVLVVGIGSGTKMLT | 126 | Q8WWH5 | |
| GVMDKTKGAVTGSVE | 136 | Q99541 | |
| KGGKGRTGTMVCALL | 321 | Q6XPS3 | |
| GGKKAREVGMGSGAE | 641 | Q5JPB2 | |
| GSGKLMGPKGVSVDR | 571 | Q9C040 | |
| GRGSRIKGIEGKFGM | 2331 | O15050 | |
| GQKGMAVLGKSEGAT | 1026 | Q702N8 | |
| MIRGKGSVKEGKVGR | 176 | Q15637 | |
| GSVKEGKVGRKDGQM | 181 | Q15637 | |
| GITVGKRGKTMLAVR | 131 | Q6IPR3 |